University of Bologna Researchers Describe Findings in Neuroblastomas (Naxitamab Activity in Neuroblastoma Cells Is Enhanced by Nanofenretinide and Nanospermidine).

Předmět:
Zdroj: Immunotherapy Weekly; 3/14/2023, p1759-1759, 1p
Abstrakt: Antibodies, Blood Proteins, Cancer, Health and Medicine, Hematology, Immunoglobulins, Immunology, Neuroblastomas, Oncology, Proteins Keywords: Antibodies; Blood Proteins; Cancer; Health and Medicine; Hematology; Immunoglobulins; Immunology; Neuroblastomas; Oncology; Proteins EN Antibodies Blood Proteins Cancer Health and Medicine Hematology Immunoglobulins Immunology Neuroblastomas Oncology Proteins 1759 1759 1 03/23/23 20230314 NES 230314 2023 MAR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Fresh data on neuroblastomas are presented in a new report. Here, we report that Nanofenretinide and Nanospermidine improved the expression of GD2 in neuroblastoma cells (CHP-134) and provided different effects in combination with the anti-GD2 antibody naxitamab. [Extracted from the article]
Databáze: Complementary Index